Iodine Alters Gene Expression in the MCF7 Breast Cancer Cell Line: Evidence for an Anti-Estrogen Effect of Iodine
Authors:
- Ari D. BrooksABAri D. Brooks
- Bernard A. EskinBEBernard A. Eskin
- Gregg J. JohannesGJGregg J. Johannes
Open Access
- 1 January 2008
- journal article
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 5 (4) , 189-196
Abstract
The protective effects of iodine on breast cancer have been postulated from epidemiologic evidence and described in animal models. The molecular mechanisms responsible have not been identified but laboratory evidence suggests that iodine may inhibit cancer promotion through modulation of the estrogen pathway. To elucidate the role of iodine in breast cancer, the effect of Lugol's iodine solution (5% I2, 10% KI) on gene expression was analyzed in the estrogen responsive MCF-7 breast cancer cell line. Microarray analysis identified 29 genes that were up-regulated and 14 genes that were down-regulated in response to iodine/iodide treatment. The altered genes included several involved in hormone metabolism as well as genes involved in the regulation of cell cycle progression, growth and differentiation. Quantitative RT-PCR confirmed the array data demonstrating that iodine/iodide treatment increased the mRNA levels of several genes involved in estrogen metabolism (CYP1A1, CYP1B1, and AKR1C1) while decreasing the levels of the estrogen responsive genes TFF1 and WISP2. This report presents the results of the first gene array profiling of the response of a breast cancer cell line to iodine treatment. In addition to elucidating our understanding of the effects of iodine/iodide on breast cancer, this work suggests that iodine/iodide may be useful as an adjuvant therapy in the pharmacologic manipulation of the estrogen pathway in women with breast cancer.Keywords
This publication has 45 references indexed in Scilit:
- Uptake and antiproliferative effect of molecular iodine in the MCF-7 breast cancer cell lineEndocrine-Related Cancer, 2006
- Functional Analyses of Glycyl-tRNA Synthetase Mutations Suggest a Key Role for tRNA-Charging Enzymes in Peripheral AxonsJournal of Neuroscience, 2006
- AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancerMolecular and Cellular Endocrinology, 2006
- Galectin-1 Interacts with the α5β1 Fibronectin Receptor to Restrict Carcinoma Cell Growth via Induction of p21 and p27Journal of Biological Chemistry, 2005
- Inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis by molecular iodine (I2) but not by iodide (I−) treatmentMolecular and Cellular Endocrinology, 2005
- Gadd45a, a p53- and BRCA1-regulated stress protein, in cellular response to DNA damageMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2005
- The Effect of Supraphysiologic Levels of Iodine on Patients with Cyclic MastalgiaThe Breast Journal, 2004
- Suppressive effect of iodine on DMBA-induced breast tumor growth in the ratJournal of Surgical Oncology, 1996
- An interferon‐induced protein with release factor activity is a tryptophanyl‐tRNA synthetaseFEBS Letters, 1992
- Thyroid disease and breast cancer: Findings in a large case-control studyBritish Journal of Surgery, 1982